ANVS
Price
$1.71
Change
+$0.16 (+10.32%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
33.13M
91 days until earnings call
CRSP
Price
$37.27
Change
-$0.32 (-0.85%)
Updated
May 13, 04:59 PM (EDT)
Capitalization
3.21B
89 days until earnings call
Ad is loading...

ANVS vs CRSP

Header iconANVS vs CRSP Comparison
Open Charts ANVS vs CRSPBanner chart's image
Annovis Bio
Price$1.71
Change+$0.16 (+10.32%)
Volume$6.25K
Capitalization33.13M
CRISPR Therapeutics AG
Price$37.27
Change-$0.32 (-0.85%)
Volume$18.15K
Capitalization3.21B
ANVS vs CRSP Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. CRSP commentary
May 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a StrongBuy and CRSP is a Buy.

Ad is loading...
COMPARISON
Comparison
May 14, 2025
Stock price -- (ANVS: $1.55 vs. CRSP: $37.59)
Brand notoriety: ANVS and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 52% vs. CRSP: 93%
Market capitalization -- ANVS: $33.13M vs. CRSP: $3.21B
ANVS [@Biotechnology] is valued at $33.13M. CRSP’s [@Biotechnology] market capitalization is $3.21B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.2B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ANVS is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while CRSP’s TA Score has 4 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 4 bearish.
  • CRSP’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than CRSP.

Price Growth

ANVS (@Biotechnology) experienced а 0.00% price change this week, while CRSP (@Biotechnology) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.49%. For the same industry, the average monthly price growth was +10.87%, and the average quarterly price growth was -7.60%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.21B) has a higher market cap than ANVS($33.1M). CRSP YTD gains are higher at: -4.497 vs. ANVS (-69.185). ANVS has higher annual earnings (EBITDA): -26.69M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. ANVS (10.6M). CRSP has higher revenues than ANVS: CRSP (35M) vs ANVS (0).
ANVSCRSPANVS / CRSP
Capitalization33.1M3.21B1%
EBITDA-26.69M-447.31M6%
Gain YTD-69.185-4.4971,538%
P/E RatioN/AN/A-
Revenue035M-
Total Cash10.6M1.9B1%
Total DebtN/A224M-
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSCRSP
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA318.3820.12
+6.75%
Tesla
AAPL210.7912.52
+6.31%
Apple
SPY582.9918.65
+3.30%
SPDR® S&P 500® ETF
GME28.050.51
+1.85%
GameStop Corp
BTC.X102812.950000-1293.406200
-1.24%
Bitcoin cryptocurrency

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+1.31%
ADXN - ANVS
43%
Loosely correlated
N/A
EWTX - ANVS
33%
Poorly correlated
+1.65%
PRME - ANVS
30%
Poorly correlated
+3.08%
TNYA - ANVS
29%
Poorly correlated
-0.68%
CRSP - ANVS
29%
Poorly correlated
+5.53%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+5.53%
BEAM - CRSP
72%
Closely correlated
+4.77%
RXRX - CRSP
72%
Closely correlated
+7.16%
NTLA - CRSP
68%
Closely correlated
+5.30%
PRME - CRSP
63%
Loosely correlated
+3.08%
ABCL - CRSP
61%
Loosely correlated
+1.48%
More